Condition: Onychomycosis · Sponsor: Oystershell NV
The efficacy and safety of ENRICHED (X92001591) will be evaluated in a multicentric, randomized, evaluator blinded clinical investigation in 88 patients.
This description comes directly from the study's public registry record.
Manon Laune, Project manager · +33472823656 · manon.laune@cpt.eurofinseu.com
Always discuss trial participation with your own doctor first.
| Eurofins Dermscan Pharmascan | Villeurbanne, France, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06689852